Download presentation
Presentation is loading. Please wait.
Published byKristina Parsons Modified over 9 years ago
1
Disease B A C SUPPLEMENTARY FIGURE 1 Molecular Function D
2
SUPPLEMENTARY FIGURE 2 A B C E D
3
AB OVCAR8 SKOV3 C D E OVCAR8SKOV3 SUPPLEMENTARY FIGURE 3
4
D E FG Paclitaxel (1µM)Gemcitabine (2µM) PEO4 (10µM)PEO4 (25µM) siControlsiLARP1 (1)siLARP1 (2) A B C SKOV3 Paclitaxel (1µM) Gemcitabine (2µM) SUPPLEMENTARY FIGURE 4
5
SKOV3 OVCAR8 HeLa A B SUPPLEMENTARY FIGURE 5 siControlsiLARP1 (1)siLARP1 (2)
6
OVCAR3IGROV-1 HeLa A B Cell lineMean CD133+ population on flow cytometry NCI60 relative expression (probe intensity – dataset minimum) SKOV3<0.1% 0 OVCAR8<0.1% 0 OVCAR35.9% 4.56 IGROV14.6% 4.71 SUPPLEMENTARY FIGURE 6
7
A B D C F Benign mucinous Mucinous carcinoma E G SUPPLEMENTARY FIGURE 7
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.